Article
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward
1 Oct 2021
Abstract excerpt
Tumors accumulate metabolites that deactivate infiltrating immune cells and polarize them toward anti-inflammatory phenotypes. We provide a comprehensive review of the complex networks orchestrated by several of the most potent immunosuppressive metabolites, highlighting the impact of adenosine, kynurenines, prostaglandin E2, and norepinephrine and epinephrine, while discussing completed and ongoing clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
